 | |||||||||||
| |||||||||||
![[California]](/stanford-ucsf-epc/images/epc-logo.jpg){kind=logo}
 Members Page Matrix of Expertise
|
| A. Eugene Washington, M.D., M.P.H., M.Sc. |
|
A. Eugene Washington (EPC Co-Director) has extensive corporate-level experience, having served in multiple leadership and management roles in academic medicine and other health organizations. He is currently Chair of the Department of Obstetrics, Gynecology and Reproductive Sciences, and Director of the Medical Effectiveness Research Center for Diverse Populations (MERC) at UCSF. As Chair, Dr. Washington is responsible for the overall management of the Department, which is one of the largest administrative units in the School of Medicine. He provides leadership for the Department's 430 faculty and staff based at three inpatient medical centers and eight additional outpatient clinical sites, and oversees the Department's annual budget of approximately $37 million. As Director of MERC, which he founded in 1993 with support from an AHRQ MEDTEP Research Center on Minority Population grant, Dr. Washington directs the research and training activities of a group of approximately two dozen faculty and collaborating investigators. At UCSF, he is currently also Director of the UCSF Women’s Reproductive Health Research Career Development Center and has assumed several other high-level leadership roles, including Co-Chair of the campus-wide Clinical Outcomes Advisory Board, Assistant Director, Clinical Epidemiology Program in the Department of Epidemiology and Biostatistics, Co-Director, Center for Reproductive Health Policy Research at the Institute for Health Policy Studies, and Director, Policy Core at the Center for AIDS Prevention Studies. Nationally, Dr. Washington has a distinguished record of organizing and leading large groups of investigators in multidisciplinary and multicenter collaborations. He served as Director of the original UCSF/Stanford EPC. He is currently PI on an AHRQ/NIH funded Program Project investigating the effectiveness of communication and decision-making in diverse population that involves projects based at the Stanford University Center for Biomedical Ethics and the Kaiser Permanente Division of Research in addition to UCSF, and is the Study Chair for an AHRQ supported multicenter randomized clinical trial comparing medical vs. surgical treatment for abnormal uterine bleeding. He also was recently PI of a study on prenatal testing decision-making, funded by the National Center for Human Genome Research, that involves measuring patient preferences at four clinical sites and conducting cost-effectiveness analyses. Finally, Dr. Washington was PI of a joint CDC and NIH project to collect, analyze and synthesize data on pelvic inflammatory disease, and Chair of the CDC/NIH Work Group that developed national prevention and management guidelines using these data. This effort involved coordinating the collection of data among investigators at five institutions across the U.S. Dr. Washington has extensive experience in analyzing and synthesizing all available data for preventing or managing a disease with the specific aim of developing evidence-based practice guidelines. He has published numerous studies involving literature review, meta-analysis, decision analysis, cost-effectiveness analysis and economic analysis. Moreover, he has organized and directed several national projects to develop evidence-based practice guidelines. Dr. Washington directed the development and publishing of three sets of clinical practice guidelines from CDC: (a) the first edition of the Sexually Transmitted Diseases Treatment Guidelines (the sixth edition is now being published in 2002); (b) the Chlamydia trachomatis Infections: Policy guidelines for prevention and management; and the Pelvic Inflammatory Disease: Guidelines for prevention and management. Data analysis and syntheses for this latter guideline culminated in an issue of JAMA dedicated to pelvic inflammatory disease in which Dr. Washington was the author of five articles. He is currently the Principal Investigator of an AHRQ-funded Excellence Center to Eliminate Ethnic/Racial Disparities (EXCEED), examining the appropriateness and effectiveness of health care services and procedures for minority populations. Dr. Washington has also served on many national and international expert panels and advisory boards and committees formed to complete reports advancing the practice of evidence-based medicine. Noteworthy among these are the U.S. Preventive Services Task Force, the Practice Guideline Committee of the American College of Preventive Medicine, the Expert Panel on Prevention and Treatment of Maternal and Newborn Infections of the World Health Organization, and the Committee on Clinical Research in the Pubic Interest of the Institute of Medicine, of which he is currently a member. Finally, he is co-author of a report with Dr. David Grimes entitled Technology Assessment: A Systematic Approach to Medical Innovation for the American College of Obstetricians and Gynecologists. |
| | |
Copyright © 1998 Stanford University All rights reserved.